MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $147,000 | +21.5% | 3,216 | -1.6% | 0.00% | 0.0% |
| Q2 2018 | $121,000 | -14.8% | 3,269 | -31.8% | 0.00% | 0.0% |
| Q1 2018 | $142,000 | -31.4% | 4,796 | -20.3% | 0.00% | -40.0% |
| Q4 2017 | $207,000 | +97.1% | 6,017 | +106.9% | 0.01% | +150.0% |
| Q3 2017 | $105,000 | -12.5% | 2,908 | -37.2% | 0.00% | -33.3% |
| Q2 2017 | $120,000 | +36.4% | 4,628 | +0.5% | 0.00% | +50.0% |
| Q1 2017 | $88,000 | +15.8% | 4,607 | +0.5% | 0.00% | 0.0% |
| Q4 2016 | $76,000 | +105.4% | 4,582 | +157.6% | 0.00% | +100.0% |
| Q3 2016 | $37,000 | – | 1,779 | +13584.6% | 0.00% | – |
| Q1 2015 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 13 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |